Morning Watch List: Bio Blast Pharma Ltd. (NASDAQ:ORPN), Axovant Sciences Ltd. (NYSE:AXON), Caesars Acquisition (NASDAQ:CACQ), Petroleo Brasileiro Petrobras (NYSE:PBR), Chesapeake Energy (NYSE:CHK)

Bio Blast Pharma Ltd. (NASDAQ:ORPN) belongs to Healthcare sector. Its weekly performance is 4.43%. On last trading day company shares ended up $6.95. Bio Blast Pharma Ltd. (NASDAQ:ORPN) distance from 50-day simple moving average (SMA50) is 12.44%. BioBlast Pharma Ltd. (NASDAQ:ORPN) said ON 29 June, that it has been granted Orphan Drug Designation by the European Commission for Cabaletta for the treatment of Spinocerebellar Ataxia or SCA. BioBlast is currently conducting a Phase 2 study in patients suffering from SCA3 in Israel.

Axovant Sciences Ltd. (NYSE:AXON) shares fell -1.82% in last trading session and ended the day at $17.24. Axovant Sciences Ltd. (NYSE:AXON) recently announced that two presentations on the company’s drug development efforts have been accepted for the 2015 International Conference of the Alzheimer’s Association (AAIC) that will take place in Washington, D.C. from the 18th until the 23rd of July, 2015.

On 13 July, Caesars Acquisition Company (NASDAQ:CACQ) shares advanced 3.70% and was closed at $7.29. CACQ EPS growth in last 5 year was 0.00%. Caesars Acquisition Company (NASDAQ:CACQ) year to date (YTD) performance is -29.29%. BTIG Research reaffirmed their buy rating on shares of Caesars Acquisition Company (NASDAQ:CACQ) in a report.

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) belongs to Basic Materials sector. Its net profit margin is 7.50% and weekly performance is 3.78%. On last trading day company shares ended up $8.51. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) distance from 50-day simple moving average (SMA50) is -6.95%. A U.S. judge has rejected Brazilian state-run oil producer Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR)’ effort to dismiss a lawsuit claiming that years of corruption, including bribery, caused more than $98 billion of its stock and bonds to be overvalued.

Chesapeake Energy Corporation (NYSE:CHK) shares fell -4.13% in last trading session and ended the day at $10.90. CHK Gross Margin is 91.10% and its return on assets is -7.40%. Chesapeake Energy Corporation (NYSE:CHK) quarterly performance is -26.20%. Chesapeake Energy Corporation (NYSE:CHK) was ordered by a U.S. federal court on Friday to pay $379.7 million to bond investors after the firm was found to have waited too long to announce a plan to redeem bonds. According to reports, U.S. District Judge Paul Engelmayer in Manhattan ruled that holders of Chesapeake’s 6.775 notes maturing in 2019 were entitled to a special “make-whole” price when Chesapeake decided to redeem $1.3 billion worth of bonds six years early.

Leave a Reply

Your email address will not be published. Required fields are marked *